(Q53251390)

12 May 2018

title

Apolipoprotein E epsilon 4 allele frequency in demented and cognitively impaired patients with and without cerebrovascular disease. (English)

1 reference

12 May 2018

5

François Boller

1 reference

12 May 2018

author name string

Latchezar Traykov

1

1 reference

12 May 2018

Anne-Sophie Rigaud

2

1 reference

12 May 2018

Sophie Baudic

3

1 reference

12 May 2018

Alain Smagghe

4

1 reference

12 May 2018

Françoise Forette

6

1 reference

12 May 2018

publication date

1 November 2002

1 reference

12 May 2018

Journal of the Neurological Sciences

published in

1 reference

12 May 2018

volume

203-204

1 reference

12 May 2018

page(s)

177-181

1 reference

12 May 2018

Apolipoprotein E genotype and Alzheimer's disease

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900287-3

Apolipoprotein E polymorphism and atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900287-3

Relation of apolipoprotein E phenotype to myocardial infarction and mortality from coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900287-3

Apolipoprotein E4 phenotype is not an important risk factor for coronary heart disease or stroke in elderly subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900287-3

Apolipoprotein E4 allele frequency, ischemic cerebrovascular disease, and Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900287-3

Apolipoprotein E polymorphism in Japanese patients with Alzheimer's disease or vascular dementia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900287-3

The frequency of apolipoprotein E4 allele is not increased in patients with probable vascular dementia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900287-3

Apolipoprotein E phenotypes in demented and cognitively impaired patients with and without cerebrovascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900287-3

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900287-3

Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900287-3

Direct phenotyping of human apolipoprotein E in plasma: application to population frequency distribution in Paris (France)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900287-3

Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer's Disease Diagnostic and Treatment Centers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900287-3

Apolipoprotein E polymorphism and silent microangiopathy-related cerebral damage. Results of the Austrian Stroke Prevention Study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900287-3

Apo E allele frequencies in Alzheimer's disease, Lewy body dementia, Alzheimer's disease with cerebrovascular disease and vascular dementia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900287-3

APOE-epsilon 4 in patients with Alzheimer disease and vascular dementia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2802%2900287-3

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0022-510X(02)00287-3

1 reference

12 May 2018

PubMed ID

12417380

1 reference

12 May 2018